Department of Urology, University of Yamanashi Interdisciplinary Graduate School of Medicine and Engineering, Chuo, Yamanashi, Japan.
Am J Physiol Renal Physiol. 2013 Feb 15;304(4):F390-6. doi: 10.1152/ajprenal.00574.2012. Epub 2012 Nov 28.
Effects of urethane on lower urinary tract function were examined in decerebrate unanesthetized rats. During single slow infusion (0.04 ml/min) cystometrograms (CMGs), urethane (0.3 g/kg) increased micturition pressure threshold (PT) by 73%, postvoid residual volume (RV) by 425%, and decreased voiding efficiency (VE) by 57%, but did not change maximal voiding pressure (MVP), closing peak pressure (CPP), bladder compliance, bladder contraction duration (BCD), or volume threshold (VT) for inducing micturition. Lower doses (0.01-0.1 g/kg) did not alter any parameter. During continuous fast infusion (0.21 ml/min) CMGs, urethane at doses of 0.6-1.2 g/kg (iv) markedly decreased CPP by 69-85%, whereas only the largest dose (1.2 g/kg iv) decreased MVP and external urethral sphincter electromyogram activity by 42 and by 80%, respectively. Doses of 0.001-0.6 g/kg did not alter the intercontraction interval and BCD. Taken together, these results suggest that urethral activity, which is essential for efficient voiding, is more sensitive to the suppressive effect of urethane than afferent or efferent mechanisms controlling the bladder. The threshold dose of MK-801 (0.3 mg/kg), an NMDA antagonist, required to decrease MVP and increase VT in urethane (1.2 g/kg)-anesthetized rats, only increased VT in rats treated with a subanesthetic dose of urethane (0.3 g/kg), suggesting a higher sensitivity of the afferent vs. efferent limb of the micturition reflex pathway to urethane-MK-801 interactions. Because effects of urethane persisted after removal of the forebrain, they must be mediated by actions on the brain stem, spinal cord, or peripheral nervous system.
在去大脑麻醉大鼠中,研究了氨基甲酸乙酯对下尿路功能的影响。在单次缓慢输注(0.04ml/min)期间,尿动力学描记图(CMG)显示,氨基甲酸乙酯(0.3g/kg)使排尿压力阈值(PT)增加了 73%,剩余尿量(RV)增加了 425%,排尿效率(VE)降低了 57%,但不改变最大排尿压力(MVP)、关闭峰值压力(CPP)、膀胱顺应性、膀胱收缩持续时间(BCD)或诱导排尿的体积阈值(VT)。较低剂量(0.01-0.1g/kg)未改变任何参数。在连续快速输注(0.21ml/min)期间,氨基甲酸乙酯(iv)剂量为 0.6-1.2g/kg 时,CPP 显著降低了 69-85%,而只有最大剂量(1.2g/kg iv)降低了 MVP 和尿道外括约肌肌电图活动,分别降低了 42%和 80%。0.001-0.6g/kg 剂量不改变收缩间期和 BCD。综上所述,这些结果表明,对于有效排尿,尿道活动对氨基甲酸乙酯的抑制作用更敏感,而不是控制膀胱的传入或传出机制。NMDA 拮抗剂 MK-801(0.3mg/kg)的阈剂量,用于降低氨基甲酸乙酯(1.2g/kg)麻醉大鼠的 MVP 和增加 VT,仅在接受亚麻醉剂量氨基甲酸乙酯(0.3g/kg)治疗的大鼠中增加 VT,这表明传入与排尿反射通路的传出支对氨基甲酸乙酯-MK-801 相互作用的敏感性更高。由于氨基甲酸乙酯的作用在去除前脑后仍然存在,因此它们必须通过对脑干、脊髓或周围神经系统的作用来介导。